Skip to main content

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

Many take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.